The global pharmaceutical industry has contended with many supply challenges in recent years, from the COVID-19 pandemic to ...

These documents are written in dense, lawyer-like language that requires individual interpretation from each function; ...

When Kailera revealed its plans for an IPO last month, there was a feeling that it could be huge – and that expectation has ...

In our final video from the LSX World Congress in Lisbon, Portugal, web editor Nicole Raleigh spoke with Paulo Neves, CMO of ...

In its announcement, OpenAI called GPT-Rosalind a "frontier reasoning model built to support research across biology, drug ...

The months-long absence of permanent leadership at the CDC could soon be at an end, after President Trump nominated former ...

The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple ...

The finding suggests the government has met its target of getting UK clinical trials up and running within an average of 150 ...

Saqib Islam, chief executive Officer of newly launched Beeline Medicines. The pace of private financing in biopharma steps up ...

The British Business Bank (BB) has agreed to make a £100 million investment in a new healthcare fund launched by London-based ...

With one approved drug (Johnson & Johnson’s Spavaro) already doing $468 million per quarter in sales, and with companies like ...

A review of clinical data on amyloid beta-targeting Alzheimer's disease therapies has concluded their efficacy is too modest ...